Hong Kong Book Fair, Sports and Leisure Expo and World of Snacks to reopen earlier at 9am tomorrow with extended evening hours 
Imagen Network (IMAGE) Enhances Social Customization with Grok AI Real-Time Processing Engines 
iconpractice Launches Version 2.0 of Cloud-Based Chiropractic Practice Management Platform 
Power Circuit Productions LLC Announces New Podcast: “The Power Circuit” Hosted by Gaurav Srivastava 
Typhoon special arrangements for Hong Kong Book Fair, Hong Kong Sports and Leisure Expo and World of Snacks Free Background Checks in Pennsylvania: How to Search Pennsylvania Arrest Records, Criminal Records, and More – Geek411
DENVER, April 25, 2021 (GLOBE NEWSWIRE) — Geek411 announces the release of the report “How…
DeepBrain Chain Mainnet Public Test Phase 2 Launched, In Collaboration With Many Other Ecosystems
SINGAPORE / ACCESSWIRE / April 23, 2021 / The first two industrial revolutions utilized real…
F Connection Concierge in St. Barthelemy Introduces Loyalty Rewards Membership Club
ST. BARTHELEMY, CARIBBEAN / ACCESSWIRE / April 23, 2021 / F Connection Concierge, a luxury…
Valley Oaks Medical Group: Healthcare Made Affordable for Medicare-Eligible Seniors
LAS VEGAS, NV / ACCESSWIRE / April 23, 2021 /Â Barriers are affecting senior citizens from…
Gracell Biotechnologies Announces Filing of Its Annual Report on Form 20-F for Fiscal Year 2020
SUZHOU and SHANGHAI, China, April 23, 2021 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc. (NASDAQ: GRCL)…
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals
LONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH) (GW)…
Ocugen Inc. Announces $100 Million Registered Direct Offering of Common Stock Priced at a Premium to Market
MALVERN, Pa., April 23, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused…
GENFIT: Publication of the 2020 Universal Registration Document and the 2020 Annual Report on Form 20-F; Annual Shareholders Meeting to take place on June 15, 2021
Lille, France; Cambridge, MA; April 23, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage…
Santhera to Announce 2020 Results on April 29, 2021
Pratteln, Switzerland, April 23, 2021 – Santhera Pharmaceuticals (SIX: SANN) will announce its audited 2020 results…
European Commission Approves JEMPERLI (dostarlimab), the First Anti-PD-1 Therapy Approved for Recurrent or Advanced dMMR/MSI-H Endometrial Cancer in Europe
PD-1 Antagonist Antibody Under Clinical Development for Solid Tumors in Collaboration with GlaxoSmithKline (GSK) First…
New Dupixent® (dupilumab) analyses reinforce long-term safety and efficacy profile in patients with atopic dermatitis as young as 6 years
     New Dupixent® (dupilumab) analyses reinforce long-term safety and efficacy profile in patients…
Arcutis Biotherapeutics Showcases New Roflumilast Data in Psoriasis and Seborrheic Dermatitis at American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2021
Detailed results from Phase 2b study of roflumilast foam in scalp and body psoriasis featured…
Brickell Biotech Reports Results from U.S. Phase 3 Open-Label, Long-Term Safety Study on Chronic Use of Sofpironium Bromide Gel as a Potential Treatment for Primary Axillary Hyperhidrosis
Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment Efficacy…
Cronos Group Inc. to Hold 2021 First Quarter Earnings Conference Call on May 7, 2021
TORONTO, April 23, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos…
Coherus Announces Toripalimab Achieved Primary Endpoints of Progression Free Survival and Overall Survival in Interim Analysis of Phase 3 Clinical Trial in First-Line Esophageal Squamous Cell Carcinoma
REDWOOD CITY, Calif., April 23, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Nasdaq: CHRS) has…
Vaxart Appoints David Wheadon, M.D., to its Board of Directors
SOUTH SAN FRANCISCO, Calif., April 23, 2021 (GLOBE NEWSWIRE) — Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage…
Timber Pharmaceuticals Announces Appointment of John Koconis as Chairman of the Board of Directors
– Edward J. Sitar appointed as Lead Independent Director of the Board – – Company…
ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Extension Trial Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a…
CHMP recommends EU approval of Roche’s ENSPRYNG (satralizumab) for adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD)
If approved, ENSPRYNG will be the first and only treatment available to both adults and…
Vistin Pharma ASA: Annual Report for 2020
Oslo, Norway, 23 April 2021 Please find attached the Annual Report for 2020 for Vistin…